PET-CT在宫颈癌诊治中的应用

曹京红; 翟建军; 初幸之

doi:10.7504/fk2015010126

中国实用妇科与产科杂志 ›› 2015, Vol. 31 ›› Issue (7) : 679-682. DOI: 10.7504/fk2015010126

综述

PET-CT在宫颈癌诊治中的应用

曹京红,翟建军,初幸之

作者信息 +

文章历史 +

摘要

妇科肿瘤常用的影像学检查方法包括超声检查、计算机断层扫描（computed tomography,CT）和核磁共振成像（magnetic resonance imaging, MRI），均属于形态学诊断方法。正电子发射体层成像-计算机断层扫描（positron emission tomography- computed tomography , PET-CT）因其实现了功能与结构成像的有机融合，近年在临床应用日益广泛。正电子发射体层成像（positron emission tomography，PET）采用正电子标记的模拟生理代谢物的放射性药物，在生理条件下追踪人体活细胞内的生物化学反应，形成功能代谢影像，在肿瘤复发、转移的诊断中具有显著优势。PET-CT结合具有高组织分辨率的CT，集中了全身显像和断层显像的优点，同时弥补了CT定性困难和PET定位不精确及由于生理性摄取造成假阳性的缺陷，提高了诊断效能和准确性，具有极高的临床应用价值。PET-CT在妇科恶性肿瘤领域应用最多、研究最深入的是宫颈癌的诊治。

导出引用

曹京红,翟建军,初幸之. PET-CT在宫颈癌诊治中的应用[J]. 中国实用妇科与产科杂志. 2015, 31(7): 679-682 https://doi.org/10.7504/fk2015010126

中图分类号： Ｒ737.3

参考文献

[1］郭慧敏，赵晋华，宋建华，等.18F-FDG PET-CT在宫颈癌初诊及随访监测中的价值［J］. 肿瘤，2011，31（3）：250-254.

[2］ Chou HH,Chang TC,Yen TC. Low value of

[18F］-fluoro-2-deoxy-D-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy［J］.J Clin Oncol,2006,24(1):123-128.

[3］ Sironi S,Buda A,Picchio M，et al. Lymph node metastasis in patients with clinical early-stage cervical cancer:detection with integrated FDG PET-CT［J］.Radiology,2006,238(1):272.

[4］郑航，陈锦章，罗荣城，等. 18F-FDG PET-CT显像对宫颈癌诊断及治疗的影响［J］.实用癌症杂志，2009，24（5）：494-497.

[5］ Yen TC,See LC,Lai CH，et al. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression［J］ .J Nucl Med,2004,45(10):22.

[6］ Loft A,Berthelsen AK,Roed H. The diagnostic value of PET-CT scanning in patients with cervical cancer:a prospective study［J］.Gynecol Oncol,2007,106(1):29-34.

[7］卢宝彦，车文颖，姚树展. PET-CT显像在宫颈癌原发灶诊断及盆腔淋巴结分期的价值［J］.医学影像学杂志，2008，18（9）：1052-1054.

[8］ Lin WC,Hung YC,Yeh LS. Usefulness of (18) F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings［J］.Gynecol Oncol，2003，89(1)：73-76.

[9］周文兰，罗湖炳，王全师，等.18F-FDG PET-CT在宫颈癌诊断中的应用［J］.中国核医学杂志，2008,28(3)：178-181.

[10］陈英汉，王丹波，李雅男，等. PET-CT在检测早期子宫颈癌淋巴结转移中的诊断价值［J］.中国医科大学学报，2013,42(4)：351-354.

[11］ Amandine P,Caroline BM,Aurore O,et al. Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma［J］. Eur J Nucl Med Molec Imaging,2010, 37(7):1270-1278.

[12］ Nam HI,Huh SJ,Ju SG,et al.18F-fluorodeoxyglucose positron emisson tomography/computed tomography guided conformal brachytherapy for cervical cancer［J］. Int J Radiat Oncol Biol Phys,2012,84(1):e29-e34.

[13］ Chung HH,Kim SK,Kim TH. Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer:from diagnosis to prognosis［J］.Gynecol Oncol,2006,103:165-170.

[14］ Sakurai H,Suzuki Y,Nonaka T. FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy-tumor volume and FDG uptake value［J］. Gynecol Oncol，2006,100:601-607.

[15］ Unger JB,Ivy JJ,Connor P.Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women［J］. Gynecol Oncol，2004,94:212-216.

[16］ Chung HH,Nam BH,Kim JW,et al. Preoperative (18F)FDG PET-CT maximum standardized uptake value predicts recurrence of uterine cervical cancer［J］. Eur J Nucl Med and Molec Imaging, 2010, 37(8):1467-1473.

[17］ Kidd EA,Siegel BA,Dehdashti P. Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer［J］.Cancer,2010,116(6):1469-1475.

[18］ Chang TC,Law KS,Hong JH.Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies:a phase II study［J］. Cancer，2004，101：164-171.

[19］ Kidd EA,Siegel BA,Dehdashti F,et al. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival［J］.Cancer,2007,110(8):1738-1744.

[20］ Yilmaz M,Adli M,Celen Z,et al. FDG PET-CT in cervical cancer: relationship between primary tumor FDG uptake and metastatic potential［J］. Nucl Med Communications，2010, 31(6)：526-531.

[21］ Grigsby PW,Siegel BA,Dehdashti F, et al. Posttherapy

[18F］ fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome［J］. J Clin Oncol，2004，22(11)：2167-2171.

[22］ Schwarz JK,Siegel BA,Dehdashti F,et al. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma［J］.JAMA,2007,298(19):2289-2295.